Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Quidel Corporation and French company bioMerieux have agreed to form a long-term global alliance in the area of rapid clinical diagnostics for the point-of-care.
Subscribe to our email newsletter
bioMerieux will become Quidel’s primary distributor for its QuickVue rapid diagnostic tests outside the US and the two companies intend to co-develop new rapid tests using Quidel’s rapid test development capability and bioMerieux’s expertise and extensive library of antibodies and antigens. The companies plan to especially leverage their mutual expertise in the area of infectious diseases.
bioMerieux will be the exclusive distributor of all of Quidel’s current QuickVue rapid diagnostic tests in all countries with the exception of the US, Japan and Scandinavia, starting in May 2008. Branding for these products is expected to reflect the strength and market power of both companies.